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Abstract 
Lupus profundus is a rare skin condition originally described by Kaposi in 1883. It is a clinical variant of LE in which the deep dermis 
and subcutaneous fat are predominantly affected. A 38-year-old female presented with history of development of well-circumscribed 
patches of hair loss since 1994 year. In 2004 on the skin of left cheek she noticed a single erythematous plaque on which place later 
became dint of subcutaneous tissue. Today she has massive defects across whole scalp, right cheek and the upper part of left arm with 
multiple ulcers(fig.3and4). case reposrt, laboratory examinations, skin biopsy and influence of corticosteroids on further progression 
/regression of this disease. 
 
Streszczenie 
Lupus Profundus jest rzadkim schorzeniem skóry pierwotnie opisanym przez Kaposiego w 1883 roku. Jest to wariant kliniczny LE, w 
którym zmiany zlokalizowane są w przewaŜającym stopniu głęboko w skórze właściwej i tkance podskórnej. 38-letnia chora zgłosiła się 
z  historią  rozwiniętych,  ograniczonych  plackowatych  ognisk  utraty  włosów  od  1994  roku.  W  2004  r.  na  skórze  lewego  policzka 
zauwaŜyła pojedynczą rumieniową zmianę, w której miejscu później powstało wgłębienie do tkanki podskórnej. Obecnie pacjentka z 
rozległymi ubytkami na całej skórze głowy, policzkach i w górnej prawej części lewego ramienia, z wieloma owrzodzeniami. Opisano 
przypadek kliniczny, wykonane badania laboratoryjne, diagnostyczne oraz wpływ kortykosteroidów na dalszy rozwój / regresję choroby. 
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Introduction 
Lupus  profundus  is  a  rare  skin  condition 
originally  described  by  Kaposi  in  1883  and  later  by 
Irgang in 1940. It is a clinical variant of LE in which the 
deep  dermis  and  subcutaneous  fat  are  predominantly 
affected. It may occur on its own or in association with 
discoid  lupus  erythematosus  (DLE)  or  SLE.  In  cases 
associated  with  SLE,  it  may  precede  SLE  by  several 
years. In the majority of cases, it tends to have a mild 
chronic course marked by recurrent nodules or plaques. 
 
Case report 
A 38-year-old female presented with history of 
development of well-circumscribed patches of hair loss 
since  1994.  year.  The  hair  loss  was  rapid  and 
asymptomatic, with no hair re-growth. 
There  was  no  family  history  of  any  autoimmune 
rheumatic diseases. 
In  2004.  she  was  first  time  hospitalised  on  our  clinic. 
Clinical  symptoms  were:  on  the  skin  of  left  cheek  a 
single,  erythematous  plaque  (Fig.  1).  On  left  arm  two 
small  ulcers  size  1 x 2 cm, oval in shape and firm in 
consistency (Fig. 2). 
Since  than  she  was  treated  with  chloroquin  in  dose 
250mg  per  day  with  gradually  reduction,  but  with  no 
results. 
Today she have massive defects across whole scalp, right 
cheek and the upper part of left arm (Fig. 3,4). 
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Figure 1. On the skin of left cheek a single,          Figure 2. On left arm two small ulcers size 1 x 2 cm,  
erythematous plaque               oval in shape and firm in consistency                 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
Figure 3. Massive defects across whole the upper    Figure 4. Massive defects across whole scalp, right cheek 
part of left arm 
 
 
The lesion, on the left arm in 2004. initially, was about 1 
Χ 2 cm 
2 in size, oval in shape and firm in consistency. It 
gradually increased in size to about 8 Χ 5 cm 
2,
 in 20l0. 
with  multiple  ulcers  colonized  with  Staphilococcus 
aureus,and  with  extensive  atrophy  of  cutaneus  and 
subcutaneous tissue. There was no history of preceding 
trauma.  No  history  of  taking  injection.  She  denied 
arthralgia,  arthropathy,  myalgia,  fatigue,  fever, 
Raynaud's  phenomenon  and  gastrointestinal  symptoms. 
She notifies pain in right lumbal area, and the ultrasound 
showed signs of bilateral nephropathy. 
The  following  laboratory  tests  were  done:  complete 
blood  cell  count,  differential  cell  count,  ESR  was  25, 
total serum proteins 86.0, with A:G ratio 1.0,y globulins 
were  increased  0.27.  Blood  sugar,  blood  urea,  serum 
creatinine,  serum  electrolytes,  liver  function  tests  and 
urinalysis were in normal rates. X-ray chest was normal. 
Rheumatoid  factor  was  normal,but  antistreptolysin  was 
221,0IU/ml. C3 1.090 g/l, C4 0.l65 g/l, ANA positive, 
Anti ds DNA negative and CiC was increased and his 
amount was 58.o8IU/ml. 
 
Skin  biopsy  showed  lymphocytic  panniculitis,  hyaline 
degeneration  of  the  fat,  hyaline  papillary  bodies,  and 
lymphoid  nodular  structures  in  the  lower  dermis  and 
subcutaneous  tissue.  Result  is  in  high  correlation  with 
diagnosis of erytematodes cronicus profundus. 
In  2010.  we  treated  her  with  systemic  corticosteroid 
therapy in dose of 60mg per day with gradually reduction 
of dose. After 2 month of therapy further progression has 
stoped  (Fig.  5,6).  Her  maintence  dose  today  is  20  mg 
prednisolon/day. 
 
Discussion 
Lupus  erythematosus  profundus or panniculitis 
is  an  unusual  but  distinct  clinical  variety  of  lupus 
erythematosus. The inflammatory reaction in takes place 
primarily  in  the  deep  corium  and  the  subcutaneous 
tissues  leading  to  deep  indurated  nodules  or  sharply 
defined  plaques.  The  overlying  skin  usually  appears 
normal but there may be erythema, atrophy, ulceration or 
poikilodermatous or hyperkeratotic changes. 
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         Figure 5. Lesions after 2 month of therapy  
Figure 6. Lesions after 2 month of therapy   
 
The  lesions  are  most  frequent  on  cheeks  but 
other sites of predilection are face, upper arms, hands, 
chest, buttocks and thighs. It may develop in association 
with  discoid  lupus  erythematosus  or  systemic  lupus 
erythematosus or may occur as an isolated phenomenon. 
The  differential  diagnoses  include  panniculitis  due  to 
other connective tissue disorders like dermatomyositis or 
scleredema and Weber Christian panniculitis or Jessner's 
lymphocytic  infiltration,  lyrnphocytoma  cults  and 
sarcoidosis.  
Lupus  panniculitis  often  responds  to  treatment  with 
antimalarials, such as hydroxychloroquine (200 mg once 
or twice a day). Some cases respond to a combination of 
antimalarials (for example, hydroxychloroquine 200 mg 
and  quinacrine  100  mg  daily)  when  monotherapy  is 
ineffective. Systemic glucocorticoids should be reserved 
for  widespread  and  resistant  lesions.  Intralesional 
glucocorticoids  are  usually  ineffective  and  may 
exacerbate  the  atrophic  healing  process.  Success  with 
dapsone,  azathioprine,  and  thalidomide  has  been 
described in isolated case reports. Surgical debridement 
or resection of individual lesions may be attempted when 
all other modalities have failed and there is appreciable 
debilitation. 
 
Conclusion 
Progress  of  Erythematodes  profundus  is 
unpredictable. As we can see on example of this patient 
therapy  with  cloroquine  was  insufficient  to  stop 
progression of disease. 
With  dose  of  60  mg  methylprednisolon  there  was  no 
more  further  progression.Today, after 8 months of last 
hospitalisation we have not noticed any progression. 
Defects on skin with which she needs to live daily, are 
horrifying,  what  caused  her  phsychiatric  problem  and 
antidepresive therapy. 
Today she stay as dermatology, surgery and cosmetology 
problem. 
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